SCHEMBL29348353

SCHEMBL29348353

O=C1CN(CCOc2ccc(-c3cccc(C4CCC(=O)NC4=O)c3Cl)cc2)CCN1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNF P01375 2/20 0.41
CD274 Q9NZQ7 3/20 0.40
PDCD1LG2 Q9BQ51 1/20 0.40
CRBN Q96SW2 6/20 0.40
DDB1 Q16531 5/20 0.39
DRD2 P14416 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
THRB P10828 2/20 0.38
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
OPRM1 P35372 1/20 0.37
PDCD1 Q15116 1/20 0.36
ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348368 0.88 TNF (0.49) TNFCRBNDDB1DRD2HRH3
SCHEMBL29348339 0.86 CRBN (0.44) TNFCD274PDCD1LG2CRBNDDB1
SCHEMBL29348350 0.82 CRBN (0.49) CD274PDCD1LG2CRBNDDB1DRD2
SCHEMBL29348358 0.80 CRBN (0.50) CD274PDCD1LG2CRBNDDB1DRD2
SCHEMBL29348367 0.79 CRBN (0.47) CD274PDCD1LG2CRBNDDB1DRD2
SCHEMBL29348356 0.79 CRBN (0.44) TNFCD274PDCD1LG2CRBNDDB1
SCHEMBL29348338 0.78 PDE10A (0.48) CRBNDDB1
SCHEMBL29348577 0.77 CRBN (0.44) CD274PDCD1LG2CRBNDDB1
SCHEMBL29348398 0.77 CRBN (0.41) TNFCD274PDCD1LG2CRBNDDB1
SCHEMBL31068109 0.77 CRBN (0.46) CD274PDCD1LG2CRBNDDB1PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed